Synthesis and HPLC-purification of [Br-77]TMC125-R165335 (etravirine), a new anti-HIV drug of the DAPY-NNRTI class
- Author
- Bart De Spiegeleer (UGent) , Filip Dumont, Kathelijne Peremans (UGent) , Christian Burvenich (UGent) , Lieven Van Vooren, J ROSIER, L BAERT, P WIGERINCK and Guido Slegers (UGent)
- Organization
-
- Department of Pharmaceutical analysis
- Department of Comparative physiology and biometrics
- Department of Pharmaceutics
- Department of Mathematical Modelling, Statistics and Bio-informatics (ceased 1-1-2018)
- Department of Veterinary medical imaging and small animal orthopaedics (ceased 1-1-2022)
- Department of Morphology, Imaging, Orthopedics, Rehabilitation and Nutrition
- Keywords
- REVERSE-TRANSCRIPTASE INHIBITORS, BR-77, bromine labelling, HPLC purification, [Br-77]TMC125-R165335 (etravirine), anti-HIV DAPY-NNRTI
Downloads
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 125.76 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-345335
- MLA
- De Spiegeleer, Bart, et al. “Synthesis and HPLC-Purification of [Br-77]TMC125-R165335 (Etravirine), a New Anti-HIV Drug of the DAPY-NNRTI Class.” JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, vol. 49, no. 8, JOHN WILEY & SONS LTD, 2006, pp. 683–86, doi:10.1002/jlcr.1085.
- APA
- De Spiegeleer, B., Dumont, F., Peremans, K., Burvenich, C., Van Vooren, L., ROSIER, J., … Slegers, G. (2006). Synthesis and HPLC-purification of [Br-77]TMC125-R165335 (etravirine), a new anti-HIV drug of the DAPY-NNRTI class. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 49(8), 683–686. https://doi.org/10.1002/jlcr.1085
- Chicago author-date
- De Spiegeleer, Bart, Filip Dumont, Kathelijne Peremans, Christian Burvenich, Lieven Van Vooren, J ROSIER, L BAERT, P WIGERINCK, and Guido Slegers. 2006. “Synthesis and HPLC-Purification of [Br-77]TMC125-R165335 (Etravirine), a New Anti-HIV Drug of the DAPY-NNRTI Class.” JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS 49 (8): 683–86. https://doi.org/10.1002/jlcr.1085.
- Chicago author-date (all authors)
- De Spiegeleer, Bart, Filip Dumont, Kathelijne Peremans, Christian Burvenich, Lieven Van Vooren, J ROSIER, L BAERT, P WIGERINCK, and Guido Slegers. 2006. “Synthesis and HPLC-Purification of [Br-77]TMC125-R165335 (Etravirine), a New Anti-HIV Drug of the DAPY-NNRTI Class.” JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS 49 (8): 683–686. doi:10.1002/jlcr.1085.
- Vancouver
- 1.De Spiegeleer B, Dumont F, Peremans K, Burvenich C, Van Vooren L, ROSIER J, et al. Synthesis and HPLC-purification of [Br-77]TMC125-R165335 (etravirine), a new anti-HIV drug of the DAPY-NNRTI class. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS. 2006;49(8):683–6.
- IEEE
- [1]B. De Spiegeleer et al., “Synthesis and HPLC-purification of [Br-77]TMC125-R165335 (etravirine), a new anti-HIV drug of the DAPY-NNRTI class,” JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, vol. 49, no. 8, pp. 683–686, 2006.
@article{345335, author = {{De Spiegeleer, Bart and Dumont, Filip and Peremans, Kathelijne and Burvenich, Christian and Van Vooren, Lieven and ROSIER, J and BAERT, L and WIGERINCK, P and Slegers, Guido}}, issn = {{0362-4803}}, journal = {{JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS}}, keywords = {{REVERSE-TRANSCRIPTASE INHIBITORS,BR-77,bromine labelling,HPLC purification,[Br-77]TMC125-R165335 (etravirine),anti-HIV DAPY-NNRTI}}, language = {{eng}}, number = {{8}}, pages = {{683--686}}, publisher = {{JOHN WILEY & SONS LTD}}, title = {{Synthesis and HPLC-purification of [Br-77]TMC125-R165335 (etravirine), a new anti-HIV drug of the DAPY-NNRTI class}}, url = {{http://doi.org/10.1002/jlcr.1085}}, volume = {{49}}, year = {{2006}}, }
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: